Loading…
Operates in Real Estate — Rental & Investment Property. Per the activity note to the FY2024 annual report, the company leases non-residential buildings and operates a retail pharmacy.
| Ratio | 2022 | 2023 | 2024 |
|---|---|---|---|
| Margins | |||
| Gross Margin | 51.8% | 48.3% | 79.8% |
| EBITDA Margin | 37.6% | 33.0% | 68.1% |
| EBITDAR | 996 | 1,250 | 3,950 |
| EBITDAR Margin | 37.6% | 33.0% | 68.2% |
| EBIT Margin | 31.1% | 20.3% | 57.7% |
| Net Profit Margin | 27.7% | -71.7% | -12.1% |
| Operating Expense % of Sales | 14.2% | 15.3% | 11.7% |
| Returns | |||
| Return on Assets (ROA) | 6.6% | -5.1% | -1.4% |
| Return on Equity (ROE) | 7.9% | -20.0% | -5.6% |
| ROIC [EBIT / Invested Capital] | 7.5% | 1.5% | 8.4% |
| Leverage & debt balances | |||
| Debt-to-Assets | 16.2% | 71.1% | 54.5% |
| Debt-to-Equity | 0.19x | 2.76x | 2.25x |
| Debt-to-EBITDA | 1.81x | 30.00x | 7.07x |
| Equity-to-Assets | 83.8% | 25.8% | 24.3% |
| Net Debt | 1,702 | 37,032 | 27,468 |
| Cash & Equivalents | 99 | 480 | 456 |
| Total Debt | 1,801 | 37,511 | 27,923 |
| Liquidity & working capital | |||
| Current Ratio | 65.74x | 0.77x | 0.06x |
| Quick Ratio | 65.74x | 0.77x | 0.06x |
| Cash Ratio | 11.74x | 0.63x | 0.05x |
| Total Current Assets | 554 | 584 | 544 |
| Total Current Liabilities | 8 | 762 | 9,667 |
| Inventory | N/A | N/A | N/A |
| Trade Receivables | 53 | 104 | 86 |
| Trade Payables | 1 | 532 | 9,470 |
| Net Working Capital | 546 | -179 | -9,123 |
| Net Working Capital % of Revenue | 20.6% | -4.7% | -157.4% |
| Trade Working Capital | 52 | -428 | -9,384 |
| Trade Working Capital % of Revenue | 2.0% | -11.3% | -161.9% |
| Change in Trade Working Capital | N/A | -480 | -8,956 |
| Turnover & efficiency | |||
| Inventory Turnover | N/A | N/A | N/A |
| Days Inventory Outstanding (DIO) | N/A | N/A | N/A |
| Receivables Turnover | 50.26x | 36.45x | 67.21x |
| Days Sales Outstanding (DSO) | 7.3 | 10.0 | 5.4 |
| Payables Turnover | 1791.77x | 3.68x | 0.12x |
| Days Payable Outstanding (DPO) | 0.2 | 99.2 | 2958.1 |
| Cash Conversion Cycle | 7.1 days | -89.1 days | -2952.7 days |
| Asset Turnover | 0.24x | 0.07x | 0.11x |
| Cash flow & dividends | |||
| Operating Cash Flow | N/A | N/A | N/A |
| Free Cash Flow (OCF − Capex proxy) | N/A | N/A | N/A |
| Cash Conversion (OCF / EBITDA) | N/A | N/A | N/A |
| Dividends Declared | N/A | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →